I’d ditto OldCrone’s question. Generally speaking, insurance companies in the US historically resisted providing “gender affirming care”. I’d be interested to know which ones lobbied the WHO to change the ICD.
It was just an announcement a couple of years after the change to the US medical listings
What are you talking about here? ICD-11 isn’t a “US medical listing.” Are you mixing it up with the DSM? The potential changes to ICD-11 were discussed and publicised well before 2018 and went through a lengthy process. At the time, the main challenge to the changes was the fact that gender incongruence was being included in the ICD at all- continued inclusion was viewed as only a partial depatholization. The decision was made to include it so individuals in countries with medical insurance would not find barriers to coverage if it were removed.
ICD-11 was the WHO pushing the patient led affirmative medical pathway via removing psychological gatekeeping. Google Geoffrey Reed if you want the background.
Right now the issue is not how we got here but how/whether the WHO can be influenced/persuaded to rethink the balance on the panel and approach to developing their guidelines.